08/01/2024
11:15 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form EFFECT | |
08/01/2024
11:15 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form EFFECT | |
08/01/2024
11:15 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form EFFECT | |
08/01/2024
11:15 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form EFFECT | |
07/19/2024
8:22 AM | eFFECTOR Therapeutics, Inc. (Subject)
eFFECTOR Therapeutics (Subject)
eFFECTOR Therapeutics, Inc. (Subject)
Nasdaq Stock Market LLC (Filed by)
| Form 25-NSE | |
06/25/2024
7:30 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/25/2024
4:16 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/24/2024
6:06 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/13/2024
5:45 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:45 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Loewy Caroline M (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:23 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Harrington-Smith Kristen (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:25 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Ehrlich Christopher B (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:35 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Klencke Barbara (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:15 PM | Bhatt Elizabeth (Reporting)
eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:19 PM | eFFECTOR Therapeutics, Inc. (Issuer)
eFFECTOR Therapeutics (Issuer)
eFFECTOR Therapeutics, Inc. (Issuer)
Gallagher Brian M. Jr. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/20/2024
7:36 AM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:51 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 424B3 | |
05/09/2024
3:06 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/09/2024
3:08 PM | eFFECTOR Therapeutics, Inc. (Filer)
eFFECTOR Therapeutics (Filer)
eFFECTOR Therapeutics, Inc. (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Buy EFTR Stock Free EFTR Stock Alerts